AlconXSWX:ALC +0.74%77 EV-to-OCF is 16.01 as of Jul. 11, 2026, which is 52% below its 10-year median of 33.13. GuruFocus rates XSWX:ALC with a GF Score™ of 77/100 and a GF Value™ of CHF73.82 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Alcon ranks worse than 68.65% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Alcon's Enterprise Value is CHF29,460 Mil.
Alcon's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,840 Mil. Therefore, Alcon's EV-to-OCF for today is 16.01.
The historical rank and industry rank for Alcon's EV-to-OCF or its related term are showing as below:
XSWX:ALC'
s EV-to-OCF Range Over the Past 10 Years
Min: 14.63 Med: 33.13 Max: 1023.48
Current: 15.9
During the past 10 years, the highest EV-to-OCF of Alcon was 1023.48. The lowest was 14.63. And the median was 33.13.
XSWX:ALC's EV-to-OCF is ranked worse than 68.65% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 7.7
vs XSWX:ALC: 15.90
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-11), Alcon's stock price is CHF54.44.
Alcon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1.325. Therefore, Alcon's PE Ratio (TTM) for today is 41.09.
Alcon (XSWX:ALC) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alcon's share price for today is CHF54.44.
Alcon's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1.325.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Alcon EV-to-OCF Related Terms
Alcon EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Alcon's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Alcon's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcon EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alcon's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Alcon's EV-to-OCF falls into.
Alcon's current Enterprise Value is CHF29,460 Mil.
Alcon's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,840 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcon (XSWX:ALC) has a EV-to-OCF of 16.01 as of Jul. 11, 2026. This is 52% below median its historical median of 33.13. Over the past decade, Alcon's EV-to-OCF has ranged from 14.63 to 1,023.48. According to the industry distribution chart, Alcon ranks #587 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 68.7%.
Is Alcon's EV-to-OCF too high?
Alcon's current EV-to-OCF of 16.01 is 52% below median its 10-year median of 33.13. Over the past 10 years, this metric has ranged from a low of 14.63 to a high of 1,023.48. The Medical Devices & Instruments industry median EV-to-OCF is 7.70. Alcon's value of 16.01 is 107.9% above this industry median. Based on the distribution chart, Alcon ranks #587 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Alcon has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Alcon ranks #587 out of 855 companies for EV-to-OCF. This places Alcon in the lower half of its industry. The industry median EV-to-OCF is 7.70. Alcon's value of 16.01 is 107.9% above this benchmark. Historically, Alcon's own EV-to-OCF has ranged from 14.63 to 1,023.48 over the past decade. While the company's 10-year median is 33.13 vs. the industry median of 7.70, Alcon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.70, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current EV-to-OCF of 16.01 is 107.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current EV-to-OCF is 16.01, which is 52% below median its own 10-year median of 33.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (XSWX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF73.82, compared to a current price of CHF54.44 — trading 26.3% below its estimated fair value. The current EV-to-OCF is 16.01, which is 52% below median its 10-year median of 33.13 and 107.9% above the Medical Devices & Instruments industry median of 7.70. Alcon's overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Alcon (XSWX:ALC), the current EV-to-OCF is 16.01 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcon (XSWX:ALC) Overvalued in 2026?
Based on GuruFocus' analysis, Alcon stock appears to be undervalued.
The current stock price of CHF54.44 is trading 26.3% below its estimated GF Value™ of CHF73.82.
GuruFocus considers Alcon to be Modestly Undervalued.
Key valuation signals for XSWX:ALC:
EV-to-OCF: 16.01 (52% below median its 10-year median of 33.13)
GF Value™: CHF73.82 vs. price of CHF54.44 (26.3% below fair value)
Industry Position: 107.9% above the Medical Devices & Instruments median (#587 of 855)
No single metric tells the full story. See the XSWX:ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
77GF Score
Get the complete analysis for XSWX:ALC
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ALC has been successfully added to your 
